Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
In a decision that could influence discovery in federal medical-device products liability litigation, a Magistrate Judge in the U.S. District Court for the Northern District of New York has held that a state-law provision designed to encourage hospitals to maintain quality assurance and infection control programs without fear of litigation can be invoked to block disclosure of hospital records even where there is, at most, an indirect threat of a malpractice suit and where the…
It is said that 'doctors bury their mistakes.' At one time that may have been more true than in modern times, and when the original peer-review privileges case came out, it seemed as if it may have been more possible to bury culpable behavior in peer-review. That is not the case in 2007.
The author, Tim O'Brien, was appointed Lead Counsel by the U.S. District Court for the Southern District of New York in MDL No. 1789, <i>In re Fosomax Products Liability Litigation</i>. The opinions expressed herein are Mr. O'Brien's and represent some of the arguments the plaintiffs are or will be making in the litigation.
Documentation is an important part of medical care. Consultation notes, test results, physician orders and nursing observations all assist in ensuring continuity of care. In litigation, however, the significance of the written chart is often elevated from a tool for patient care to historical written account of past events. In this latter context, many in the medical community have advocated that if an event (an order, a consultation, a phone call, etc.) was not documented in the official patient record, it did not happen. Over time, this 'negative evidence' has been used to prove negligent omissions on the part of various care providers by showing that they failed to do something that they should have done, because if it had been done it would have been charted. The same 'lack of entry' evidence is also used to disprove (or create doubt) that an event testified to by a witness on the stand did not occur.
Features
The latest happenings in this important area.
Hospitals have a legal duty to make health care as safe as is possible so that the hospital, through practitioners under its aegis, can offer the proper standard of care. When the hospital fails in this regard, a lawyer may consider a negligent credentialing claim where the hospital did not appropriately credential a practitioner and a direct claim of negligence against the hospital where the institution did not have sufficient policies and procedures, and carry them out, in order to protect patients.
For more than one year, product liability cases have been pending against Merck's osteoporosis drug, Fosamax'. Despite having one of the highest side effect profiles of any drug in the U.S. prescription database, Fosamax remains on the market, and available by prescription. When a drug remains on the market during litigation but the manufacturer refuses to warn about a known risk, places the information about the risk in an obscure location or provides inadequate information about the severity of the risk, there is a public problem ' for both patients and prescribers alike ' in the form of a health hazard about which most prescribers have insufficient information.